Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited

NEU.AX
Neuren Pharmaceuticals LimitedAU flagAustralian Securities Exchange
16.40
AUD
-0.25
- -
2.08BMarket Cap

Total Valuation

Neuren Pharmaceuticals Limited carries a market capitalization of 2.08B, placing it among publicly traded companies globally.

Market Cap2.08B
Enterprise ValueN/A

Stock Price Statistics

Neuren Pharmaceuticals Limited's stock has gained approximately 16.97575% over the past 52 weeks. The 50-day moving average sits at 13.55, while the 200-day moving average is 15.98.

Beta (5Y)N/A
52-Week Price Change16.97575%
50-Day Moving Average13.55
200-Day Moving Average15.98
Average Volume (20 Days)N/A

Stock Splits

Neuren Pharmaceuticals Limited's most recent stock split took place on November 21, 2017 with a 20:1 split ratio.

Last Split Date11/21/2017
Split Ratio20:1